Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1306

Jan 13, 2021

Researchers create a highly sensitive biohybrid olfactory sensor

Posted by in categories: bioengineering, biotech/medical, chemistry, evolution

A keen sense of smell is a powerful ability shared by many organisms. However, it has proven difficult to replicate by artificial means. Researchers combined biological and engineered elements to create what is known as a biohybrid component. Their volatile organic compound sensor can effectively detect odors in gaseous form. They hope to refine the concept for use in medical diagnosis and the detection of hazardous materials.

Electronic devices such as cameras, microphones and pressure sensors enable machines to sense and quantify their environments optically, acoustically and physically. Our sense of smell however, despite being one of nature’s most primal senses, has proven very difficult to replicate artificially. Evolution has refined this sense over millions of years and researchers are working hard to catch up.

“Odors, airborne chemical signatures, can carry useful information about environments or samples under investigation. However, this information is not harnessed well due to a lack of sensors with sufficient sensitivity and selectivity,” said Professor Shoji Takeuchi from the Biohybrid Systems Laboratory at the University of Tokyo. “On the other hand, biological organisms use information extremely efficiently. So we decided to combine existing biological sensors directly with artificial systems to create highly sensitive volatile organic compound (VOC) sensors. We call these biohybrid sensors.”

Jan 13, 2021

Parabiosis: the Dilution Solution?

Posted by in categories: biotech/medical, life extension

Summary: Scientists have long marveled at the rejuvenating effects of heterochronic parabiosis. When you mix the blood of a young mouse and an old mouse by joining their circulatory systems, the older animal recovers some features of youth, while the young animal becomes functionally older. While many have assumed that these effects were driven by the infusion of pro-youth factors from the young parabiont into the older one, an alternative “Dilution Solution” hypothesis is possible: that the young blood is instead diluting pro-aging factors from the old animal’s blood, as well as allowing the young animal’s livers and kidneys to filter out metabolic toxins through the young animals’ livers and kidneys.


In heterochronic parabiosis, joining the circulatory systems of young and old mice causes the older animal to recover some features of youth. The effect has been widely assumed to be driven by pro-youth factors in younger blood, but an alternative hypothesis is possible: that the procedure is instead diluting pro-aging factors in the older partner.

Jan 13, 2021

Researchers identify promising model for studying human aging

Posted by in categories: biotech/medical, life extension, neuroscience

Aging research fans might like.

“In their work, Hamiliton’s team found that the Dunkin Hartley guinea pig was a good candidate for a muscle aging model due to the animal’s tendency to develop osteoarthritis (OA) at a young age.”


There are many components to aging, both mental and physical. When it comes to the infrastructure of the human body—the musculoskeletal system that includes muscles, bones, tendons and cartilage—age-associated decline is inevitable, and the rate of that decline increases the older we get. The loss of muscle function—and often muscle mass—is scientifically known as sarcopenia or dynapenia.

Continue reading “Researchers identify promising model for studying human aging” »

Jan 13, 2021

Artificial Flesh

Posted by in categories: biological, biotech/medical, ethics, food, futurism, health, innovation, science, sustainability

Review: Meat Planet (2019) by Benjamin Aldes Wurgaft

In the words of the book’s author, Benjamin Aldes Wurgaft, Meat Planet: Artificial Flesh and the Future of Food (2019) is “not an attempt at prediction but rather a study of cultured meat as a special case of speculation on the future of food, and as a lens through which to view the predictions we make about how technology changes the world.” While not serving as some crystal ball to tell us the future of food, Wurgaft’s book certainly does serve as a kind of lens.

Our very appetites are questioned quite a bit in the book. Wondering about the ever-changing history of food, the author asks, “Will it be an effort to reproduce the industrial meat forms we know, albeit on a novel, and more ethical and sustainable, foundation?” Questioning why hamburgers are automatically the default goal, he points out cultured meat advocates should carefully consider “the question of which human appetite for meat, in historical terms, they wish to satisfy.”

Wurgaft’s question of “which human appetite” – past, present, or future – is an excellent one. If we use his book as a lens to observe other emerging technologies, the question extends well beyond our choices of food. It could even have direct implications for such endeavours as radical life extension. Will we, if we extend our lifetimes, be satisfactory to future people? We already know the kind of clash that persists between different generations, and the blame we often place on previous generations for current social ills, without there also being a group of people who simply refuse to die. We should be wary of basing our future on the present – of attempting to preserve present tastes as somehow immutable and deserving immortality. This may be a problem such futurists as Ray Kurzweil, author of The Singularity is Near (2005) need to respond to.

If we are to justify the singularity at which we or our appetites are immortalized, we should remember technology changes “morality’s horizon”, as Wurgaft observes. If, for example, a new technology arises that can entirely eliminate suffering, our choice to allow suffering is an immoral one. If further technologies then emerge that can eliminate not just suffering but death, it will become immoral on that day to permit someone’s natural death – at least to the extent it is like the crime of manslaughter. I argued in my own book that it will be immoral to withhold novel biotechnologies from impoverished countries, if we know such direct action will increase their economic independence or improve their health. Put simply, our inaction in a situation can become an immoral deed if we have the necessary tools to stop suffering.

Continue reading “Artificial Flesh” »

Jan 13, 2021

Dr Halima Benbouza — Leading Biotech Development In Algeria For Health, Agriculture and Conservation

Posted by in categories: bioengineering, biotech/medical, education, food, genetics, government, health

Dr. Halima Benbouza is an Algerian scientist in the field of agronomic sciences and biological engineering.

She received her doctorate in 2004 from the University Agro BioTech Gembloux, Belgium studying Plant Breeding and Genetics and was offered a postdoctoral position to work on a collaborative project with the Agricultural Research Service, United States Department of Agriculture in Stoneville, Mississippi.

Continue reading “Dr Halima Benbouza — Leading Biotech Development In Algeria For Health, Agriculture and Conservation” »

Jan 13, 2021

Aubrey de Grey Longevity Q&A — The last 25 years, SENS, Longevity Escape Velocity, & More

Posted by in categories: bioengineering, biotech/medical, cryonics, life extension, mathematics, neuroscience

Annotated!


Aubrey David Nicholas Jasper de Grey is an English author and biomedical gerontologist. He is the Chief Science Officer of the SENS Research Foundation and VP of New Technology Discovery at AgeX Therapeutics.
Feel free to ask any related questions that you want Aubrey to try and answer!

Continue reading “Aubrey de Grey Longevity Q&A — The last 25 years, SENS, Longevity Escape Velocity, & More” »

Jan 12, 2021

Dream Chaser space plane’s first flight slips to 2022 due to pandemic-related delays

Posted by in categories: biotech/medical, habitats, space travel

Sierra Nevada, the spaceship’s maker, is also building the LIFE space habitat.


Delays, many related to COVID, have pushed the first flight of the Dream Chaser space plane to 2022.

Jan 12, 2021

New method helps pocket-sized DNA sequencer achieve near-perfect accuracy

Posted by in categories: biotech/medical, engineering

Researchers have found a simple way to eliminate almost all sequencing errors produced by a widely used portable DNA sequencer, potentially enabling scientists working outside the lab to study and track microorganisms like the SARS-CoV-2 virus more efficiently.

Using special molecular tags, the team was able to reduce the five-to-15 percent error rate of Oxford Nanopore Technologies’ MinION device to less than 0.005 percent—even when sequencing many long stretches of DNA at a time.

“The MinION has revolutionized the field of genomics by freeing DNA sequencing from the confines of large laboratories,” says Ryan Ziels, an assistant professor of civil engineering at the University of British Columbia and the co-lead author of the study, which was published this week in Nature Methods. “But until now, researchers haven’t been able to rely on the device in many settings because of its fairly high out-of-the-box error rate.”

Jan 12, 2021

DNA in water used to uncover genes of invasive fish

Posted by in categories: biotech/medical, food

Invasive round goby fish have impacted fisheries in the Great Lakes and the Finger Lakes by competing with native species and eating the eggs of some species of game fish.

But the camouflaged bottom dwellers can be difficult to find and collect—especially when they first enter a new body of water and their numbers are low and they might be easier to remove.

In a proof-of-principle study, Cornell researchers describe a new technique in which they analyzed environmental DNA—or eDNA—from in Cayuga Lake to gather nuanced information about the presence of these invasive fish.

Jan 12, 2021

A potential vaccine for multiple sclerosis

Posted by in categories: biotech/medical, neuroscience

(MS) has been announced by a collaboration including BioNTech, with a study in mice showing great promise for improving symptoms and stopping disease progression.